Abstract 18676: Anti-miR33 Therapy Induces PGC1a Expression to Regulate Immunometabolic Pathways in Atherosclerosis and Obesity
Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Zongbin Wu(Dalian Institute of Chemical Physics), Eleni Ramphos(University of Ottawa), Michèle Geoffrion(University of Ottawa), Mary‐Ellen Harper(University of Ottawa), A. Brianne Thrush(University of Ottawa), Kathryn J. Moore(New York University)
Cited by 0
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k